BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 13, 2007
View Archived Issues
Medarex announces 2007 second quarter results
Read More
Subjective effects of memantine in smokers
Read More
Talnetant potentiates monoaminergic neurotransmission induced by atypical antipsychotics
Read More
Recent patent claims novel short peptides for the treatment of endometriosis
Read More
Seikagaku claims new drugs for osteoporosis
Read More
Novel oncolytic compounds reported in recent patents
Read More
Bayer and Nektar launch agreement on novel therapy for Gram-negative pneumonias
Read More
GammaCan obtains FDA orphan drug designation for VitiGam in melanoma
Read More
The Medicines Company files sNDA to expand Angiomax label
Read More
Welichem Biotech's antipsoriatic drug candidate enters phase I clinical trial
Read More
FDA issues not approvable letter for GSK's Advair 500/50
Read More
Neuromed and Merck & Co. discontinue development of NMED-160
Read More
Biomira and Merck amend Stimuvax collaboration
Read More
Positive interim results for Genaera's phase I study of trodusquemine for obesity
Read More
Abraxis and Biocon sign licensing agreement for commercialization of Abraxane
Read More
Epix cites results from phase IIa trial of 5-HT2B antagonist in COPD-associated PH
Read More
Phosphagenics cites positive phase Ib transdermal insulin clinical trial results
Read More
Particle-mediated delivery of H5N1 vaccine holds promise for the prophylaxis of influenza
Read More
Targeting amyloid-beta, a novel approach in glaucoma therapy
Read More
FDA approves Spectrum's SPI-1620 IND
Read More
FDA accepts Regeneron's BLA for IL-1 Trap rilonacept
Read More
Patient enrollment begins for ImClone's phase II study of IMC-11F8
Read More
IND for Active Biotech's phase II study of TASQ approved by FDA
Read More
Alnylam reports closing of Roche alliance
Read More
Sirtris begins phase Ib trial of SRT-501 for MELAS
Read More